Brainstorm Cell (NQ: BCLI )

5.236 USD +0.056 (+1.07%)

Streaming Delayed Price Updated: 11:24 AM EST, Nov 25, 2020 Add to My Watchlist

Price and Volume

Volume	674,840
Open	5.160
Bid (Size)	5.230 (11)
Ask (Size)	5.240 (4)
Prev. Close	5.180
Today's Range	5.110 - 5.440
52wk Range	3.630 - 17.95
Shares Outstanding	19,111,326
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND

November 23, 2020

- Dr. Merit Cudkowicz and Dr. Ralph Kern presentation will be featured in Oral Presentation in the Clinical Trials Platform Session

BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study

November 17, 2020

Clinical trial did not meet statistical significance in primary efficacy endpoint

Performance

YTD	+27.08%	+27.08%
1 Month	-48.72%	-48.72%
3 Month	-55.82%	-55.82%
6 Month	-20.79%	-20.79%
1 Year	+32.21%	+32.21%

More News

Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility

October 26, 2020

Notable Friday Option Activity: NVCR, INO, BCLI

November 20, 2020

Interesting BCLI Put And Call Options For January 2021

November 20, 2020

Mid-Afternoon Market Update: Nasdaq Turns Positive; Cinedigm Shares Slide

November 17, 2020

12 Healthcare Stocks Moving In Tuesday's Intraday Session

November 17, 2020

Mid-Day Market Update: Sequential Brands Gains After Q3 Results; Brainstorm Cell Therapeutics Shares Plunge

November 17, 2020

Mid-Morning Market Update: Markets Open Lower; Walmart Beats Q3 Views

November 17, 2020

12 Healthcare Stocks Moving In Tuesday's Pre-Market Session

November 17, 2020

Why BrainStorm Cell Therapeutics Stock Imploded Today

November 17, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.